贝达药业股票讨论区

The high P/E ratio of Betta Pharmaceuticals Co., Ltd. can be attributed to anticipated strong growth and better performance than the market. Shareholders seem to be holding on to the stock, expecting a more prosperous future based on these prospects.

Analysts express uncertainty over Betta Pharmaceuticals' performance given the gap between company metrics and industry growth. Observations point to insignificance of benefits from reinvestments for investors due to low ROE and flat earnings growth.